Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Blanco Vaca

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|December 1, 1996
Susceptibility of plasma low- and high-density lipoproteins to oxidation in patients with severe hyperhomocysteinemiaA Córdoba-Porras, J L Sánchez-Quesada, F González-Sastre, et al.
Diabetologia|July 1, 2005
Atorvastatin does not decrease or delay diabetes onset in two different mouse models of type 1 diabetesX Palomer, L Calpe-Berdiel, J Verdaguer, et al.
Diabetes & Metabolism|December 7, 2010
Effect of atorvastatin on lipoprotein (a) and interleukin-10: a randomized placebo-controlled trialC Hernández, G Francisco, A Ciudin, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 27, 2000
Determinants of plasma homocyst(e)ine in patients with nephrotic syndromeJ Joven, R Arcelús, J Camps, et al.
Biochimica Et Biophysica Acta|November 18, 2000
Increased production of very-low-density lipoproteins in transgenic mice overexpressing human apolipoprotein A-II and fed with a high-fat dietJ Julve, J C Escolà-Gil, A Marzal-Casacuberta, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|August 2, 2001
Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertensionJ Rubies-Prat, J Ordóñez-Llanos, S Martin, et al.
Clinical Chemistry|September 3, 1999
Pitfalls of direct HDL-cholesterol measurements in mouse models of hyperlipidemia and atherosclerosisJ C Escolà-Gil, O Jorba, J Julve-Gil, et al.
Journal of Lipid Research|August 18, 2000
Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemiaJ C Escolà-Gil, J Julve, A Marzal-Casacuberta, et al.
Journal of Lipid Research|February 22, 2001
ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearanceJ C Escolà-Gil, J Julve, A Marzal-Casacuberta, et al.
Medicina Clinica|September 23, 1989
[Tangier disease: study of the first case in Spain]A Leal Luna, F Blanco Vaca, J A Gómez Gerique, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Journal of Molecular Medicine (Berlin, Germany)|December 1, 1996
Susceptibility of plasma low- and high-density lipoproteins to oxidation in patients with severe hyperhomocysteinemiaA Córdoba-Porras, J L Sánchez-Quesada, F González-Sastre, et al.
Diabetologia|July 1, 2005
Atorvastatin does not decrease or delay diabetes onset in two different mouse models of type 1 diabetesX Palomer, L Calpe-Berdiel, J Verdaguer, et al.
Diabetes & Metabolism|December 7, 2010
Effect of atorvastatin on lipoprotein (a) and interleukin-10: a randomized placebo-controlled trialC Hernández, G Francisco, A Ciudin, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 27, 2000
Determinants of plasma homocyst(e)ine in patients with nephrotic syndromeJ Joven, R Arcelús, J Camps, et al.
Biochimica Et Biophysica Acta|November 18, 2000
Increased production of very-low-density lipoproteins in transgenic mice overexpressing human apolipoprotein A-II and fed with a high-fat dietJ Julve, J C Escolà-Gil, A Marzal-Casacuberta, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|August 2, 2001
Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertensionJ Rubies-Prat, J Ordóñez-Llanos, S Martin, et al.
Clinical Chemistry|September 3, 1999
Pitfalls of direct HDL-cholesterol measurements in mouse models of hyperlipidemia and atherosclerosisJ C Escolà-Gil, O Jorba, J Julve-Gil, et al.
Journal of Lipid Research|August 18, 2000
Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemiaJ C Escolà-Gil, J Julve, A Marzal-Casacuberta, et al.
Journal of Lipid Research|February 22, 2001
ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearanceJ C Escolà-Gil, J Julve, A Marzal-Casacuberta, et al.
Medicina Clinica|September 23, 1989
[Tangier disease: study of the first case in Spain]A Leal Luna, F Blanco Vaca, J A Gómez Gerique, et al.
Pageof 6